Your browser doesn't support javascript.
loading
SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication.
Denholm, Justin T; McBryde, Emma S; Eisen, Damon; Street, Alan; Matchett, Elizabeth; Chen, Caroline; Shultz, Thomas Ray; Biggs, Beverly; Leder, Karin.
Affiliation
  • Denholm JT; Victorian Tuberculosis Program, Melbourne Health, Melbourne, Victoria, Australia.
  • McBryde ES; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Eisen D; Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria, Australia.
  • Street A; Division of Tropical Health and Medicine, James Cook University, Townsville, Queensland, Australia.
  • Matchett E; Division of Tropical Health and Medicine, James Cook University, Townsville, Queensland, Australia.
  • Chen C; Townsville Hospital, Townsville, Queensland, Australia.
  • Shultz TR; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Biggs B; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Leder K; Department of Pharmacy, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Intern Med J ; 47(12): 1433-1436, 2017 12.
Article in En | MEDLINE | ID: mdl-29224209
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rifampin / Cost-Benefit Analysis / Latent Tuberculosis / Disease Eradication / Isoniazid / Antitubercular Agents Type of study: Clinical_trials / Health_economic_evaluation / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Intern Med J Journal subject: MEDICINA INTERNA Year: 2017 Type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rifampin / Cost-Benefit Analysis / Latent Tuberculosis / Disease Eradication / Isoniazid / Antitubercular Agents Type of study: Clinical_trials / Health_economic_evaluation / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Intern Med J Journal subject: MEDICINA INTERNA Year: 2017 Type: Article Affiliation country: Australia